Otolaryngology Doctors in Terre Haute, IN Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Fred Duane Drake, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1429 N 6th St, Terre Haute, IN 47807 Phone: 812-242-3170    Fax: 812-235-3330

Dr. Barry A Long, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4601 S 7th St, Terre Haute, IN 47802 Phone: 812-232-6673    Fax: 812-232-1519

Curtis Seitz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1429 N 6th St, Terre Haute, IN 47807 Phone: 812-242-3170    Fax: 812-235-3330

Martin H Roseff, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1429 N 6th St, Terre Haute, IN 47807 Phone: 812-242-3170    Fax: 812-235-3330

News Archive

Cow's milk decreases the body's ability to absorb oral thyroid hormone medication

Taking the common oral thyroid hormone medication levothyroxine with a glass of cow's milk significantly decreases the body's ability to absorb the drug, a preliminary study finds. Results will be presented Sunday at ENDO 2017, the Endocrine Society's 99th annual meeting in Orlando, Fla.

Blood pressure self-monitoring can help patients with hypertension to stick with exercise program

Using blood pressure self-monitoring is an effective way to empower patients with hypertension to stick with an exercise program, according to a first-of-its-kind study conducted by a multidisciplinary team of UConn researchers in collaboration with Hartford Hospital.

Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference

Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.

Illumina announces price reduction in whole human genome sequencing projects

Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

DAWN trial: Mechanical thrombectomy plus medication significantly decreases post-stroke disability

Results from the DAWN stroke trial presented at the European Stroke Organization Conference provide compelling evidence that selected patients suffering a major ischemic stroke recovered significantly better with mechanical retrieval of the blood clot with medical therapy compared with medical therapy alone when initiated past the current guidelines of within 6 hours and up to 24 hours of the stroke.

Read more Medical News

› Verified 8 days ago